We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Surprising Twist of Placebo Effect Revealed

By HospiMedica International staff writers
Posted on 04 Nov 2016
A new study finds that patients who knowingly took a placebo, in combination with standard treatment, experience greater pain reduction than patients who receive standard treatment alone.

Researchers at Beth Israel Deaconess Medical Center (BIDMC; Boston, MA, USA) and Instituto Superior de Psicologia Aplicada (ISPA; Lisbon, Portugal) conducted a randomized controlled trial in 97 adults with persistent low back pain confirmed by a board-certified pain specialist. More...
All patients were given a 15-minute explanation of the placebo effect. Half of them were then randomly allocated to a treatment as usual (TAU) group, in which patients were required to continue with their standard treatment.

The other half were allocated to an open-label placebo (OLP) group, in which alongside with standard treatment, patients were instructed to take one placebo pill twice daily. The pills were presented in a bottle clearly labeled "placebo pills” that stated the pills contained microcrystalline cellulose and no active medication. Pain severity was assessed on three scales scoring maximum pain, minimum pain, and usual pain, and a composite total pain score. In all, 83 adults completed the trial.

The results showed that patients in the TAU group experienced a 9% reduction in usual pain and a 16% reduction in maximum pain at the end of the three weeks; however, patients in the OLP group reported a 30% reduction in both usual and maximum pain, and a 29% decline in pain-related disability. The researchers suggest the results show that patients do not necessarily need to believe they are receiving an active medication in order for the placebo effect to arise. The study was published on October 13, 2016, in Pain.

“The benefit of being immersed in treatment - interacting with a physician or nurse, taking pills, all the rituals and symbols of our healthcare system; the body responds to that,” said senior author Professor Ted Kaptchuk, DAOM, director of the program for placebo studies at BIDMC. “You're never going to shrink a tumor or unclog an artery with placebo intervention; it's not a cure-all, but it makes people feel better, for sure. Our lab is saying you can't throw the placebo into the trashcan. It has clinical meaning, it's statically significant, and it relieves patients. It's essential to what medicine means.”

The placebo -- Latin for 'I will please' -- effect is a phenomenon wherein about one third of those taking a sham drug for various complaints (including pain, headache, and seasickness) will experience relief from symptoms. The underlying mechanism remains mysterious, but the effect has been attributed to many things, such as regression to the mean, spontaneous improvement, reduction of stress, misdiagnosis in the first place, subject expectancy, classical conditioning, and more.

Related Links:
Beth Israel Deaconess Medical Center
Instituto Superior de Psicologia Aplicada

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.